Sebia EMEA Export

🟠𝐀𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐍𝐒 𝐥𝐨𝐜𝐚𝐥 𝐈𝐠𝐆 𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 is key to diagnosing #MultipleSclerosis and other neurological conditions. 🔎 Discover how our advanced solution supports faster and more confident diagnosis. ➡️ To learn more click here: https://lnkd.in/eEMVVeXv #MSAwareness #Neurology #OCBTesting #Healthcare #LabDiagnostics #LaboratoryScience #ClinicalResearch #Sebia #CSF #Diagnosis #Neuroscience #HealthInnovation

🟠Did you know that 𝐂𝐒𝐅 𝐨𝐥𝐢𝐠𝐨𝐜𝐥𝐨𝐧𝐚𝐥 𝐛𝐚𝐧𝐝𝐢𝐧𝐠 𝐢𝐬 𝐭𝐡𝐞 𝐠𝐨𝐥𝐝 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐚𝐬𝐬𝐚𝐲 for diagnosing #𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐒𝐜𝐥𝐞𝐫𝐨𝐬𝐢𝐬, and is included in international guidelines? ✅𝐄𝐚𝐫𝐥𝐲 𝐚𝐧𝐝 𝐚𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 can help speed up diagnosis and ensure patients receive the right treatment sooner. 🔎 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐨𝐮𝐫 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 to support labs worldwide in delivering 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐭 𝐎𝐂𝐁 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧. Stay tuned for more insights on best practices for MS diagnosis and care. ➡️ To learn more click here: https://lnkd.in/gAzwbnp8 #MSAwareness #Neurology #OCBTesting #Healthcare #LabDiagnostics #LaboratoryScience #ClinicalResearch #Sebia #CSF #Diagnosis #Neuroscience #HealthInnovation

🎉 Thank you to our 2000 followers! 🎉 We are excited to announce that we’ve reached 𝟐𝟎𝟎𝟎 𝐟𝐨𝐥𝐥𝐨𝐰𝐞𝐫𝐬 in just 𝐨𝐧𝐞 𝐲𝐞𝐚𝐫! Your support and engagement inspire us every day to continue innovating and sharing valuable content in the diagnostic field. A huge thank you to each of you for your trust and loyalty. We look forward to strengthening our collaboration and providing even more value in the months to come. 🚀What’s next? Our goal is to reach 𝟑𝟎𝟎𝟎 𝐟𝐨𝐥𝐥𝐨𝐰𝐞𝐫𝐬 and engage even more with all of you to build a stronger and more connected community! #2000followers #Thankyou #Diagnostic #Oncology #MetabolicDisease #GeneticDisease #AutoimmuneDisease #InflammatoryDisease #Community #SebiaEMEAExport

🟠 Awareness about #𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐒𝐜𝐥𝐞𝐫𝐨𝐬𝐢𝐬 doesn’t end with just one month, in March. ❓Did you know that over 𝟐.𝟗 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐩𝐞𝐨𝐩𝐥𝐞 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞 are affected by MS? 🔬 𝐄𝐚𝐫𝐥𝐲 𝐚𝐧𝐝 𝐚𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐢𝐬 𝐜𝐫𝐮𝐜𝐢𝐚𝐥 𝐟𝐨𝐫 𝐛𝐞𝐭𝐭𝐞𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬. At Sebia we’re committed to supporting healthcare professionals with advanced diagnostics solution, helping detect oligoclonal bands with confidence. Stay tuned for more insights this April as we continue to highlight MS detection and care. ➡️ To learn more click here: https://lnkd.in/e2cSfqNV #MSAwareness #Neurology #OCBTesting #Healthcare #LabDiagnostics #LaboratoryScience #ClinicalResearch #Sebia #CSF #Diagnosis #Neuroscience #HealthInnovation

🟠 Awareness about #𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐒𝐜𝐥𝐞𝐫𝐨𝐬𝐢𝐬 doesn’t end with just one month, in March. ❓Did you know that over 𝟐.𝟗 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐩𝐞𝐨𝐩𝐥𝐞 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞 are affected by MS? 🔬 𝐄𝐚𝐫𝐥𝐲 𝐚𝐧𝐝 𝐚𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐢𝐬 𝐜𝐫𝐮𝐜𝐢𝐚𝐥 𝐟𝐨𝐫 𝐛𝐞𝐭𝐭𝐞𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬. At Sebia we’re committed to supporting healthcare professionals with advanced diagnostics solution, helping detect oligoclonal bands with confidence. Stay tuned for more insights this April as we continue to highlight MS detection and care. ➡️ To learn more click here: https://lnkd.in/e2cSfqNV #MSAwareness #Neurology #OCBTesting #Healthcare #LabDiagnostics #LaboratoryScience #ClinicalResearch #Sebia #CSF #Diagnosis #Neuroscience #HealthInnovation

💡 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐏𝐚𝐫𝐯𝐨𝐯𝐢𝐫𝐮𝐬 𝐁𝟏𝟗 Fifth disease (erythema infectiosum) is one of the classic childhood diseases and can result from a primary infection with parvovirus B19. Infections of seronegative pregnant women with parvovirus B19 can lead to transmission of the virus to the fetus, which bears the risk of harm to the unborn child. 🔍 𝐒𝐞𝐫𝐨𝐥𝐨𝐠𝐲 The determination of parvovirus B19-specific IgG and IgM antibodies supports the diagnosis of parvovirus B19 infections and is of particular importance for determining the immune status, e.g. for pregnancy. 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐀𝐥𝐞𝐠𝐫𝐢𝐚 𝐀𝐧𝐭𝐢-𝐏𝐚𝐫𝐯𝐨𝐯𝐢𝐫𝐮𝐬 𝐁𝟏𝟗 𝐌𝐨𝐧𝐨𝐭𝐞𝐬𝐭𝐬 ⤵️ https://lnkd.in/eCX_npgg 🔬 𝐋𝐚𝐛-𝐨𝐧-𝐚-𝐒𝐭𝐫𝐢𝐩 : 𝐀𝐥𝐞𝐠𝐫𝐢𝐚 𝐀𝐧𝐭𝐢-𝐏𝐚𝐫𝐯𝐨𝐯𝐢𝐫𝐮𝐬 𝐁𝟏𝟗 𝐌𝐨𝐧𝐨𝐭𝐞𝐬𝐭𝐬 𝐛𝐲 #𝐒𝐞𝐛𝐢𝐚 Sebia´s Alegria Anti-Parvovirus B19 IgG and IgM Abs. Monotests enable the reliable determination of IgG and IgM antibodies against parvovirus B19 in combination with the compact and fully automated Alegria 2 random access device. #InfectiousDiseases #Sebia #Diagnostics #DiseaseDiagnostics #PatientCare

It is now possible to 𝐦𝐨𝐧𝐢𝐭𝐨𝐫 𝐌𝐢𝐧𝐢𝐦𝐚𝐥 𝐑𝐞𝐬𝐢𝐝𝐮𝐚𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (MRD) in 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 with a simple blood draw🩸. #MRD negativity is associated with better clinical outcomes. 🔬Current techniques for #𝐌𝐑𝐃 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 require painful bone marrow aspirate and provide limited MRD timepoints. ✨𝐌-𝐢𝐧𝐒𝐢𝐠𝐡𝐭 𝐢𝐬 𝐛𝐫𝐢𝐧𝐠𝐢𝐧𝐠 𝐭𝐡𝐞 𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐌𝐑𝐃 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐭𝐨 𝐞𝐥𝐞𝐯𝐚𝐭𝐞 𝐲𝐨𝐮𝐫 𝐌𝐑𝐃 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐭𝐨 𝐚 𝐧𝐞𝐰 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐨𝐟 𝐞𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞! ✔️𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐨𝐮𝐫 𝐥𝐚𝐬𝐭 𝐩𝐨𝐬𝐭𝐞𝐫 presented and discover other publications related to 𝐌𝐑𝐃 𝐭𝐫𝐚𝐜𝐤𝐢𝐧𝐠 𝐢𝐧 𝐛𝐥𝐨𝐨𝐝 𝐢𝐧 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 & 𝐀𝐋 𝐀𝐦𝐲𝐥𝐨𝐢𝐝𝐨𝐬𝐢𝐬 on our website: https://lnkd.in/dmspMFWC #MassSpectrometry #MinimalResidualDisease #MyelomaActionMonth #MyelomaAwarenessMonth #MultipleMyeloma #MinSight #Sebia

Busy and exciting Day 1 for Sebia at #Biomedica2025 Stop by Medical Supply Company (MSC) booth #C5 to connect with MSC and Sebia teams and explore our latest innovative solutions. See you there! #Biomedica #Sebia #Diagnostics #Innovation #AutoimmuneDiseases #InfectiousDiseases #Alegria2 #CapillaryElectrophoresis #HbA1c #Immunotyping #Hemoglobinopathies

𝐉𝐨𝐢𝐧 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 [𝐌𝐄𝐄𝐓𝐈𝐍𝐆] 𝐨𝐟 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 𝐍𝐞𝐭𝐰𝐨𝐫𝐤! 📅 Save the Date: April 10th to April 12th, 2025 📍Location: Athens, Greece Want to know more about our Next Generation #MRD solution in blood M-inSight ? 👥 Meet our Sebia experts on booth #6: ➡ https://lnkd.in/d4GA2F8m 💬 Let us know in the comments if you'll be joining us at #EMN Looking forward to welcoming you soon! #Myeloma #Sebia #MedicalConference #Healthcare #EMN2025 #MinSight

🟣 🩺Did you watch our @Sebia #webinar 𝐑𝐞𝐜𝐞𝐧𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐒𝐞𝐫𝐮𝐦 𝐅𝐫𝐞𝐞 𝐋𝐢𝐠𝐡𝐭 𝐂𝐡𝐚𝐢𝐧 𝐀𝐬𝐬𝐚𝐲𝐬 𝐟𝐨𝐫 𝐏𝐥𝐚𝐬𝐦𝐚 𝐂𝐞𝐥𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 yet? 🎥 Don't worry, you can watch the replay now: https://lnkd.in/dfnqzmKZ 🎙️ Dr. Willrich and Dr. Dispenzieri from Mayo Clinic (USA) have recently shared insights into Serum Free Light Chain assays for plasma cell disorders. #MyelomaAwareness #CancerAwareness #Diagnostics #HealthcareInnovation #BloodCancer #MultipleMyeloma #Sebia